Owner Lonza Biologics PLC.

Inventors Birch, John; Shaw, Martyn; Boraston, Robert Charles

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003226960

PCT Number PCT/EP03/00454

PCT Pub. Number WO2003/054172

Priority 0200977.7 17.01.02 GB; 02027189.6 05.12.02 EP; 60/412,586 05.09.02 US

Filing date 17 January 2003

Wipo publication date 9 July 2003

Acceptance publication date 22 November 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C07K 14/505 (2006.01) Peptides having more than 20 amino acids

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 5/22 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Human cells

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione